Human rights and the use of psychiatric medication
Lourdes Rodriguez del Barrio, Rosana Onocko Campos, Sabrina Stefanello, Deivisson Vianna Dantas dos Santos, Céline Cyr, Lisa Benisty, Thais Mikie de Carvalho Otanari
Journal of Public Mental Health
Formal recognition of the human rights of people living with mental health problems has greatly progressed. We must ask ourselves, however, to what extent the formal recognition of these rights has transformed the culture of psychiatric care and improved their quality of life. Gaining Autonomy & Medication Management (GAM) is an approach that strives to empower service users and providers and promotes the exercise of users' rights by transforming their relationship with the central component of psychiatric treatment in community services: psychopharmacology. This article shows how GAM highlights the issues surrounding the establishment of a culture of rights.
For this analysis qualitative data was collected in Brazil and in Quebec, Canada, through over a hundred interviews done with people living with mental health issues and practitioners who participated in the different GAM implementation projects.
Issues, challenges and obstacles facing the instauration of a human rights culture in mental health services are presented. The profound changes that the understanding and exercise of users’ rights bring to the lives of individuals are supported by excerpts illustrating recurring issues, situations and common experiences that appear in the various contexts of the two different countries.
This is not a parallel study taking place into two countries. The methodologies used were different, and as a consequence the comparative power can be limited. However, the results reveal striking similarities.
There is scant research on human rights in mental health services in the community, and the issues surrounding the prescribing and follow-up of pharmacological treatment. The joint analysis of the researches in Brazil and in Canada, identified common challenges which are intertwined with the dominant approach of biomedical psychiatry.